1 Vegetarian Acid-Resistant Capsule(s) · 2 serving(s) a day
Days of supply
30
Potency per day
30,000,000,000 CFU
Cost per day
no observed price in this release
Printed claims
2 on the label (All Other, Structure/Function). A printed claim is not evidence and does not enter any axis.
Other ingredients
2 printed: Microcrystalline Cellulose, Capsule
Label target groups
Adult (18 - 50 Years), Women (not pregnant or lactating), Gluten Free
Suggested use
Suggested Usage: As a dietary supplement, adults take 1 capsule 1-2 times daily or as directed by your health professional.
UPC
3 10539 97881 8
Printed potency
Quantity on the label
15,000,000,000 CFU per serving across 8 of 8 printed organism rows; potency basis Potency is stated at manufacture. 8 rows sit inside a proprietary blend, so their individual amounts are not disclosed.
Evidence behind the label
Located human trials per organism
Organism on this label
PubMed records indexed as human randomized controlled trials
Counts describe records matching each organism's published query, including trials of multi-ingredient products; they are not a count of trials of this product.
Context
Where this score sits
This formulation scores above 88.9% of the 4,101 scored formulations in this release. The score is a preference-dependent summary of the axes, not a health claim.
Evidence queries are incomplete. A2 uses the known matching records as a lower bound.
Scored using the available matching evidence. Identity: A commercial strain code is printed. Quantity disclosure: 100.0%. Potency: Potency is stated at manufacture.
Axes 3–4
Measurement and brand panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Observed price
undefined: no permitted price observation in this release
Sensitivity
Preference-dependent summary
Preference interval 76.33–79.84; rank uncertainty 272.00–1827.00; rank class 1.
Versions
Typed label snapshot edges
176590 → 237993: snapshot comparison. One of these two snapshots carries no parsed ingredient rows, so the formulas cannot be compared. The registry states no change here rather than reading the whole formula as newly added.
30982 → 237993: snapshot comparison. One of these two snapshots carries no parsed ingredient rows, so the formulas cannot be compared. The registry states no change here rather than reading the whole formula as newly added.
5280 → 237993: snapshot comparison. One of these two snapshots carries no parsed ingredient rows, so the formulas cannot be compared. The registry states no change here rather than reading the whole formula as newly added.
58190 → 237993: snapshot comparison. One of these two snapshots carries no parsed ingredient rows, so the formulas cannot be compared. The registry states no change here rather than reading the whole formula as newly added.
Preference tool
Weights slider
The readout recomputes the arithmetic summary from the published component JSON. Axis fields remain primary.
Brand: Douglas Laboratories — every published product of this brand, its potency basis and its observed reformulations.
Ivitskiy, I. (2026). Douglas Laboratories Multi-Probiotic 15 Billion. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/p/multi-probiotic-15-billion/
Douglas Laboratories Multi-Probiotic 15 Billion: 8 of 8 observed organisms name a strain, and 0 print a deposit identifier. Latest observed label 237993. Window: NIH DSLD snapshot Sep 2026.
Douglas Laboratories Multi-Probiotic 15 Billion: 1 of 1 selected label snapshots have a numeric Gut Index Score; GIS 79.36 on the 100-point scale; rank class 1 of 4 across 3,279 scored formulations; nominal weights varied from 80.0% to 120.0% in preference sensitivity. Window: NIH DSLD snapshot Sep 2026.
Douglas Laboratories Multi-Probiotic 15 Billion has 2 observed versions across 1 formulation groups; last recorded edge type: same product. Window: NIH DSLD snapshot Sep 2026.
Douglas Laboratories Multi-Probiotic 15 Billion: 0 of 2 observed versions have numeric prices; latest price No numeric price observation is available in this release.. Window: NIH DSLD snapshot Sep 2026.